- Central Pontine Myelinolysis in a Normonatremic Patient with Depression
-
Liu YC, Yang YK, Chen PS, Chang WH
- KMID: 2519566
- Clin Psychopharmacol Neurosci.
- 2021 Aug;19(3):564-567.
- doi: 10.9758/cpn.2021.19.3.564
A 76-year-old male presented with a recurrent depressive episode, an unsteady gait and cognitive impairment. Extensive blood tests, including hemogram, biochemical tests, folic acid, vitamin B12, and thyroid hormone, showed... -
- CITED
-
- Close
- SHARE
-
- Close
- Imaging of Cardiac and Pericardial Masses
-
Wu PW, Chen SJ, Lin WC, Chang CB, Chuang WY, Hsu MY, Liu YC, Chu JJ, Lin PJ, Wen MS, Hung KC, Wan YL
- KMID: 2524828
- Cardiovasc Imaging Asia.
- 2017 Jan;1(1):23-37.
- doi: 10.22468/cvia.2016.00059
Cardiac tumors are uncommon, with primary cardiac tumors being exceedingly rare. Benign primary cardiac tumors are more common than malignant primary cardiac tumors. Common benign cardiac tumors include myxoma, lipoma,... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson's Disease
-
Wang HL, Lu CS, Yeh TH, Shen YM, Weng YH, Huang YZ, Chen RS, Liu YC, Cheng YC, Chang HC, Chen YL, Chen YJ, Lin YW, Hsu CC, Lin HL, Chiu CH, Chiu CC
- KMID: 2467758
- J Clin Neurol.
- 2019 Oct;15(4):488-495.
- doi: 10.3988/jcn.2019.15.4.488
BACKGROUND AND PURPOSE: It is essential to develop a reliable predictive serum biomarker for Parkinson's disease (PD). The accumulation of alpha-synuclein (αSyn) and up-regulated expression of Rab35 participate in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
-
Liu YC, Kim SL, Park YR, Lee ST, Kim SW
- KMID: 2425158
- Intest Res.
- 2017 Apr;15(2):174-181.
- doi: 10.5217/ir.2017.15.2.174
BACKGROUND/AIMS: Parthenolide (PT), a principle component derived from feverfew (Tanacetum parthenium), is a promising anticancer agent and has been shown to promote apoptotic cell death in various cancer cells. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-kappaB Signaling in HCT116 Human Colorectal Cancer Cells
-
Kim HY, Kim SL, Park YR, Liu YC, Seo SY, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW
- KMID: 2174471
- Intest Res.
- 2015 Jul;13(3):233-241.
- doi: 10.5217/ir.2015.13.3.233
BACKGROUND/AIMS: Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-kappaB (NF-kappaB) activity. Parthenolide... -
- CITED
-
- Close
- SHARE
-
- Close
